Results 71 to 80 of about 790 (151)

Feline Cryptococcosis due to Cryptococcus gattii VGII (Recently Renamed as C. deuterogattii) in an FIV‐Positive Cat With Demodicosis From Manaus, Central Amazon, Brazil

Case Reports in Veterinary Medicine, Volume 2025, Issue 1, 2025.
This case report documents the diagnosis and successful treatment of cryptococcosis caused by Cryptococcus gattii VGII in a 20‐month‐old male domestic shorthair cat from Manaus, Brazil, which was concurrently infected with feline immunodeficiency virus (FIV) and diagnosed with demodicosis.
Nayara de Fátima Lazameth-Diniz, Adriana Oliveira da Silva Queiroz, Flávia da Silva Fernandes, João Fernando Vieira Ennes, Naira Sulany Oliveira de Sousa, Ana Claudia Alves Cortez, Jacqueline da Silva Batista, Eveleise Samira Martins Canto, Kátia Santana Cruz, Ani Beatriz Jackisch-Matsuura, Ormezinda Celeste Cristo Fernandes, Suanni Lemos de Andrade, Érica Simplício de Souza, Hagen Frickmann, João Vicente Braga de Souza, Katerina K. Adamama Moraitou   +15 more
wiley   +1 more source

Evaluation of oral fluralaner (Bravecto®) for efficacy against nymphs of Amblyomma americanum and Rhipicephalus sanguineus (sensu lato)

Parasites & Vectors, 2020
Background Amblyomma americanum and Rhipicephalus sanguineus (sensu lato) nymphs commonly feed on and transmit pathogens to dogs (Canis familiaris). Control of immature and adult tick life stages is necessary to fully protect animals.
Kelly Allen, Susan Little, Melissa Petersen, Jeff Gruntmeir, Anne Barrett, Brian Herrin, Lindsay Starkey, Fangshi Sun, Frank Guerino   +8 more
doaj   +1 more source

Evaluation of acaricide treatments to experimentally reduce winter tick load on moose

Wildlife Society Bulletin, Volume 48, Issue 4, December 2024.
We experimentally reduced winter tick load on moose calves by testing the effectiveness of two acaricide treatments: topical permethrin (5% alone) and a combination of topical permethrin (44%) and orally administered fluralaner (25 mg/kg). We resighted moose calves through recaptures, necropsies or spring flyovers.
Delphine De Pierre, Florent Déry, Anthony Asselin, Patrick A. Leighton, Steeve D. Côté, Jean‐Pierre Tremblay   +5 more
wiley   +1 more source

Safety of fluralaner chewable tablets (BravectoTM), a novel systemic antiparasitic drug, in dogs after oral administration

Parasites & Vectors, 2014
Background Fluralaner is a novel systemic insecticide and acaricide that provides long acting efficacy in dogs after a single oral treatment. This study investigated the safety of oral administration of fluralaner in chewable tablets to dogs at the ...
Feli M Walther, Mark J Allan, Rainer KA Roepke, Martin C Nuernberger   +3 more
doaj   +1 more source

Treatment of Sarcoptic Mange in Wombats With Topical Moxidectin

Veterinary Medicine and Science, Volume 10, Issue 6, November 2024.
Two bare‐nosed wombats with sarcoptic mange were treated with three 100‐mL doses of moxidectin topically approximately seven days apart. Blood was collected for clinical health assessment and to measure plasma concentrations of moxidectin. Both wombats improved, with skin becoming clear of crusting and dermatitis after two weeks.
Hayley J. Stannard, Marie B. Wynan, Ray J. Wynan, Amanda Cox, Howard Ralph, Gregory S. Doran   +5 more
wiley   +1 more source

Safety of fluralaner oral solution, a novel systemic poultry red mite treatment, for chicken breeders’ reproductive performances

Parasites & Vectors, 2017
Background Poultry mites are the most significant pest affecting production systems in the chicken egg-laying industry, altering the health condition of the birds, and causing stress, mortality and decline of egg quality impacting economic performance ...
Bruno Huyghe, Gaelle Le Traon, Annie Flochlay-Sigognault   +2 more
doaj   +1 more source

A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto™ (fluralaner) against Frontline™ (fipronil) in flea- and tick-infested dogs

Parasites & Vectors, 2014
Background Fluralaner, a new molecular entity of the isoxazoline class, has potent insecticidal and acaricidal activity and can be safely administered orally to dogs.
Nadja Rohdich, Rainer KA Roepke, Eva Zschiesche   +2 more
doaj   +1 more source

A randomized controlled trial of the efficacy of orally administered fluralaner (Bravecto™) against induced Ixodes holocyclus (Australian paralysis tick) infestations on dogs

Parasites & Vectors, 2015
Background Ixodes holocyclus ticks are a frequently fatal threat to dogs in eastern Australia. These ticks secrete a neurotoxin that can produce an ascending paralysis after 72 h attachment that can lead to death in affected animals.
Petr Fisara, Maurice Webster
doaj   +1 more source

A randomized, blinded, controlled, multi-centered field study assessing the treatment of gastrointestinal nematode infections in cats with fluralaner plus moxidectin spot-on solution (Bravecto® Plus)

Parasites & Vectors, 2018
Background A spot-on formulation containing fluralaner (280 mg/ml) plus moxidectin (14 mg/ml) (Bravecto® Plus) was developed for the treatment of nematode infections as well as providing 12 weeks of protection against insect and acarine parasites in cats.
Nadja Rohdich, Eva Zschiesche, Oliver Wolf, Wolfgang Loehlein, Zvezdelina Kirkova, Petar Iliev, Dhimitër Rapti, Rezart Postoli, Balázs Capári, Róbert Farkas, Rainer K. A. Roepke   +10 more
doaj   +1 more source

Effectiveness of a fluralaner spot-on formulation in a case of feline demodicosis due to

Journal of Feline Medicine and Surgery Open Reports, 2022
Case summary A 7-year-old male domestic shorthair cat was presented with a non-pruritic erythematous crusted nasal hypotrichosis along with bilateral ceruminous otitis externa. The cat was diagnosed with diabetes mellitus and was positive for feline immunodeficiency virus (FIV).
Pavlina Bouza-Rapti, Anatoli Tachmazidou, Rania Farmaki   +2 more
openaire   +1 more source